The Patent Finder

Respira Therapeutics, Inc.

14 patents currently held · Updated Nov 19, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Dec 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 15, 2027
    The maintenance fee for Powder dispersion devices and methods (US 10,441,733) comes due Apr 15, 2027. Unpaid by Oct 15, 2027, it lapses early.
  • 2 fees due May 5 to 7, 2027 · next May 5
  • 1 fee due Jul 7, 2027
    The maintenance fee for Powder Dispersion Methods and Devices (US 10,525,216) comes due Jul 7, 2027. Unpaid by Jan 7, 2028, it lapses early.
  • 1 fee due Aug 27, 2027
    The maintenance fee for PDE5 inhibitor powder formulations and methods relating thereto (US 11,911,390) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,651,104Bead-containing dry powder inhaler
In force
 · USPTO record
In forceUSPTO record
US 8,561,609Dry powder inhaler
In force
 · USPTO record
In forceUSPTO record
US 11,471,623Powder Dispersion Methods and Devices
In force
 · Low confidence
In forceLow confidence
US 11,806,314PDE5 inhibitor powder formulations and methods relating thereto
In force
 · USPTO record
In forceUSPTO record
US 12,364,701PDE5 inhibitor powder formulations and methods relating thereto
In force
 · USPTO record
In forceUSPTO record
US 11,911,390PDE5 inhibitor powder formulations and methods relating thereto
In force
 · USPTO record
In forceUSPTO record
US 10,441,733Powder dispersion devices and methods
In force
 · USPTO record
In forceUSPTO record
US 10,463,815Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
In force
 · USPTO record
In forceUSPTO record
US 10,525,216Powder Dispersion Methods and Devices
In force
 · Low confidence
In forceLow confidence
US 10,682,476Powder inhaler, system and methods
In force
 · USPTO record
In forceUSPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 7 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited